India has become a key pillar of Osstem Implant’s global expansion strategy, as the country’s dental implant sector undergoes a significant transformation. The Korean dental implant manufacturer is at the forefront of this change, emerging as a trusted partner for Indian dentists and patients alike.

For years, European manufacturers dominated the global dental implant industry. In recent times, however, Korean companies have risen as strong competitors, reshaping the competitive landscape.

Osstem Implant now ranks third in global market share, exporting to over 100 countries and operating 37 subsidiaries across 32 nations. 

The company’s success in India – one of the fastest-growing markets – is driven by a dual focus on innovation and education. With five implant designs and four surface technologies, Osstem offers tailored solutions for diverse patient needs. Osstem also invests heavily in training local dentists. Its flagship "Master Course" was held over 100 times across India last year, with more than 1,300 dentists completing the programme.

Osstem’s technological excellence is supported by strong scientific evidence. A study published in the international journal Materials highlighted the effectiveness of Osstem’s SA surface treatment in promoting osseointegration and bone density. Its best-selling product, TS III, has consistently demonstrated high clinical success rates across multiple studies.

Financially, Osstem Implant continues to deliver robust growth. In 2024, it reported consolidated revenues of USD 930 million (approximately KRW 1.3 trillion), with nearly 70 percent of sales generated overseas. India, along with China and Russia, ranked among its fastest-growing markets. Analysts attribute this performance not to cost competitiveness but to sustained investment in R&D, product innovation, and professional education.

In 2024, Osstem Implant reported consolidated revenues of USD 930 million (approximately KRW 1.3 trillion), with nearly 70 percent generated from overseas markets. India, along with China and Russia, ranked among its fastest-growing markets.

 According to analysts, this success is not driven by low-cost strategies but by continuous investment in R&D, product innovation, and professional education.

Beyond implants, Osstem also develops and sells a wide range of medical and dental products. Its portfolio includes advanced equipment such as unit chairs, CT scanners, and panoramic imaging devices, alongside high-quality dental materials including bone grafts, impression materials, and bleaching agents.